Kim H - Search Results

1

Sustained Mutant KIT Activation in the Golgi Complex Is Mediated by PKC-θ in Gastrointestinal Stromal Tumors.

Kim WK, Yun S, Park CK, Bauer S, Kim J, Lee MG, Kim H. Kim WK, et al. Among authors: kim h, kim j. Clin Cancer Res. 2017 Feb 1;23(3):845-856. doi: 10.1158/1078-0432.CCR-16-0521. Epub 2016 Jul 20. Clin Cancer Res. 2017. PMID: 27440273

2

Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation.

Choi YR, Kim H, Kang HJ, Kim NG, Kim JJ, Park KS, Paik YK, Kim HO, Kim H. Choi YR, et al. Among authors: kim jj, kim h, kim ho, kim ng. Cancer Res. 2003 May 1;63(9):2188-93. Cancer Res. 2003. PMID: 12727838

3

Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumors.

Kang HJ, Nam SW, Kim H, Rhee H, Kim NG, Kim H, Hyung WJ, Noh SH, Kim JH, Yun CO, Liu ET, Kim H. Kang HJ, et al. Among authors: kim h, kim ng, kim jh. Oncogene. 2005 Feb 3;24(6):1066-74. doi: 10.1038/sj.onc.1208358. Oncogene. 2005. PMID: 15690055

4

Differentially expressed proteins in gastrointestinal stromal tumors with KIT and PDGFRA mutations.

Kang HJ, Koh KH, Yang E, You KT, Kim HJ, Paik YK, Kim H. Kang HJ, et al. Among authors: kim h, kim hj. Proteomics. 2006 Feb;6(4):1151-7. doi: 10.1002/pmic.200500372. Proteomics. 2006. PMID: 16402362

5

Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.

Lee YS, Kim JH, Choi KJ, Choi IK, Kim H, Cho S, Cho BC, Yun CO. Lee YS, et al. Among authors: kim h, kim jh. Clin Cancer Res. 2006 Oct 1;12(19):5859-68. doi: 10.1158/1078-0432.CCR-06-0935. Clin Cancer Res. 2006. PMID: 17020994 Free article.

6

Gastrointestinal stromal tumor of the rectum: an analysis of seven cases.

Baik SH, Kim NK, Lee CH, Lee KY, Sohn SK, Cho CH, Kim H, Pyo HR, Rha SY, Chung HC. Baik SH, et al. Among authors: kim h, kim nk. Surg Today. 2007;37(6):455-9. doi: 10.1007/s00595-006-3424-1. Epub 2007 May 28. Surg Today. 2007. PMID: 17522761

7

Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib.

Cho BC, Im CK, Park MS, Kim SK, Chang J, Park JP, Choi HJ, Kim YJ, Shin SJ, Sohn JH, Kim H, Kim JH. Cho BC, et al. Among authors: kim yj, kim h, kim sk, kim jh. J Clin Oncol. 2007 Jun 20;25(18):2528-33. doi: 10.1200/JCO.2006.10.4166. J Clin Oncol. 2007. PMID: 17577030 Clinical Trial.

8

MicroRNA expression profiles in serous ovarian carcinoma.

Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH, Kim JW, Kim S. Nam EJ, et al. Among authors: kim h, kim sw, kim s, kim yt, kim jw, kim jh. Clin Cancer Res. 2008 May 1;14(9):2690-5. doi: 10.1158/1078-0432.CCR-07-1731. Clin Cancer Res. 2008. PMID: 18451233

9

Synaptic scaffolding molecule binds to and regulates vasoactive intestinal polypeptide type-1 receptor in epithelial cells.

Gee HY, Kim YW, Jo MJ, Namkung W, Kim JY, Park HW, Kim KS, Kim H, Baba A, Yang J, Kim E, Kim KH, Lee MG. Gee HY, et al. Among authors: kim jy, kim e, kim h, kim ks, kim kh, kim yw. Gastroenterology. 2009 Aug;137(2):607-17, 617.e1-4. doi: 10.1053/j.gastro.2009.01.065. Gastroenterology. 2009. PMID: 19642226

10

MicroRNA expression profile of gastrointestinal stromal tumors is distinguished by 14q loss and anatomic site.

Choi HJ, Lee H, Kim H, Kwon JE, Kang HJ, You KT, Rhee H, Noh SH, Paik YK, Hyung WJ, Kim H. Choi HJ, et al. Among authors: kim h. Int J Cancer. 2010 Apr 1;126(7):1640-50. doi: 10.1002/ijc.24897. Int J Cancer. 2010. PMID: 19795448

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101,771 results

Search Page

Filters